Expulsion and continuation rates of the levonorgestrel 52 mg intrauterine system was similar among nulligravid and parous users.
Eliza BrullHelymar Costa MachadoLuis BahamondesCassia Raquel Teatin JuliatoPublished in: International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics (2021)
Nulligravid and parous participants who used the 52 mg LNG-IUS showed similar expulsion and continuation rates during five years of use.
Keyphrases